In the present investigation, our in vitro and in vivo data suggested that the inhibition of SREBP2 in the sepsis model suppressed systemic inflammation and mitigated vital organ dysfunction, thereby prolonging the survival of CLP mice. The gene discussed is SREBF2; the disease is Sepsis.